HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoya Toriu Selected Research

Everolimus

5/2018Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoya Toriu Research Topics

Disease

3Proteinuria
11/2020 - 05/2019
2Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 05/2019
2Hemorrhage
05/2018 - 01/2018
1Virus Diseases (Viral Diseases)
12/2023
1Human Influenza (Influenza)
12/2023
1Pneumonia (Pneumonitis)
12/2023
1COVID-19
12/2023
1Infections
12/2023
1Fibrosis (Cirrhosis)
10/2023
1Reperfusion Injury
10/2023
1Inflammation (Inflammations)
10/2023
1Diabetic Nephropathies (Diabetic Nephropathy)
11/2020
1Glomerulonephritis
11/2020
1Amyloid Plaque
01/2020
1Immunoglobulin Light-chain Amyloidosis
01/2020
1Sarcoidosis (Schaumann Disease)
10/2019
1Embolism (Embolus)
10/2019
1Chronic Kidney Failure (Chronic Renal Failure)
10/2019
1Secondary Hyperparathyroidism
06/2019
1Nail-Patella Syndrome (Syndrome, Nail-Patella)
06/2019
1Osteoporosis
06/2019
1Neoplasms (Cancer)
06/2019
1Thrombotic Microangiopathies
05/2019
1Neoplasm Metastasis (Metastasis)
05/2019
1Thrombotic Thrombocytopenic Purpura
05/2019
1Angiomyolipoma
05/2018
1Tuberous Sclerosis (Bourneville's Disease)
05/2018
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2018
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2018
1Immune System Diseases (Immune Disorders)
01/2018
1Thrombosis (Thrombus)
01/2018
1Hypoglycemia (Reactive Hypoglycemia)
01/2018
1Cysts
01/2018
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2018

Drug/Important Bio-Agent (IBA)

2CreatinineIBA
11/2020 - 05/2018
1Amino AcidsFDA Link
12/2023
1NucleotidesIBA
12/2023
1CytokinesIBA
10/2023
1Small Nuclear RNA (snRNA)IBA
10/2023
1RNA (Ribonucleic Acid)IBA
10/2023
1ChemokinesIBA
10/2023
1Immunoglobulin G (IgG)IBA
11/2020
1tegafur-gimeracil-oteracilIBA
11/2020
1Furosemide (Lasix)FDA LinkGeneric
11/2020
1Prednisolone (Predate)FDA LinkGeneric
11/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Bence Jones ProteinIBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Melphalan (Alkeran)FDA LinkGeneric
01/2020
1Vincristine (Oncovin)FDA LinkGeneric
01/2020
1CalciumIBA
10/2019
1CholesterolIBA
10/2019
1SteroidsIBA
10/2019
1Bevacizumab (Avastin)FDA Link
05/2019
1EverolimusFDA Link
05/2018
1Proteins (Proteins, Gene)FDA Link
05/2018
1LipidsIBA
05/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Blood Glucose (Blood Sugar)IBA
01/2018
1ApolipoproteinsIBA
01/2018
1Immunoglobulin M (IgM)IBA
01/2018

Therapy/Procedure

4Therapeutics
01/2020 - 01/2018
1Nutrition Therapy (Medical Nutrition Therapy)
11/2020
1Colectomy
11/2020
1Lasers (Laser)
01/2020
1Stem Cell Transplantation
01/2020
1Parathyroidectomy
06/2019
1Renal Dialysis (Hemodialysis)
06/2019
1Microbubbles
01/2018
1Catheters
01/2018